trending Market Intelligence /marketintelligence/en/news-insights/trending/uztjxs7pgdoxnbrjfgbdkw2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Arena Pharmaceuticals plans common stock offering

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Arena Pharmaceuticals plans common stock offering

Arena Pharmaceuticals Inc. plans to sell 7.5 million of its common stock in an underwritten public offering.

The company plans to grant the underwriters an option to buy up to an additional 1,125,000 shares.

Citigroup, Leerink Partners, Cantor, Credit Suisse and RBC Capital Markets are acting as joint book-running managers, while Guggenheim Securities and JMP Securities are acting as co-managers for the offering.